Skip to main content
Signal8

MANHARD KIMBERLY

SEC insider (Form 3/4/5 filer). CIK 0001202094. Director at Inhibrx Biosciences, Inc. (INBX). 7 reported Form 4/5 transactions since Sep 2024; latest on Sep 15, 2026. Located in LA JOLLA, CA.

Companies MANHARD KIMBERLY has filed insider reports for

  • Inhibrx Biosciences, Inc. (INBX): Director
MANHARD KIMBERLY profile photo

MANHARD KIMBERLY

CIK: 0001202094

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)5 (71.4%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (28.6%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Inhibrx Biosciences, Inc. logo
INBX

Inhibrx Biosciences, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (7 total)

  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 15, 2026
    Sale
    Indirect
    500 shares at avg. $105.05$53K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 14, 2026
    Sale
    Indirect
    500 shares at avg. $110.26$55K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 11, 2026
    Sale
    Indirect
    500 shares at avg. $111.78$56K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 9, 2026
    Sale
    Indirect
    500 shares at avg. $115.80$58K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Sep 8, 2026
    Sale
    Indirect
    500 shares at avg. $115.14$58K
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    Jun 3, 2026
    Award

    Stock Option (right to buy)

    Direct
    10K shares-
  • Inhibrx Biosciences, Inc. logo
    INBX

    Inhibrx Biosciences, Inc.

    May 28, 2025
    Award

    Stock Option (right to buy)

    Direct
    15K shares-

1-7 of 7